(S)-2-((S)-2-acetamido-6-aminohexanamido)-N1-((S)-1-((R)-5-guanidino-1-oxo-1-(thiazol-2-yl)pentan-2-ylamino)-4-methyl-1-oxopentan-2-yl)pentanediamide

ID: ALA3745775

Chembl Id: CHEMBL3745775

PubChem CID: 127042186

Max Phase: Preclinical

Molecular Formula: C28H48N10O6S

Molecular Weight: 652.82

Molecule Type: Protein

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCCNC(=N)N)C(=O)c1nccs1

Standard InChI:  InChI=1S/C28H48N10O6S/c1-16(2)15-21(26(44)36-18(8-6-12-34-28(31)32)23(41)27-33-13-14-45-27)38-25(43)20(9-10-22(30)40)37-24(42)19(35-17(3)39)7-4-5-11-29/h13-14,16,18-21H,4-12,15,29H2,1-3H3,(H2,30,40)(H,35,39)(H,36,44)(H,37,42)(H,38,43)(H4,31,32,34)/t18-,19+,20+,21+/m1/s1

Standard InChI Key:  PFSNIQDNVQKULM-ANULTFPQSA-N

Alternative Forms

  1. Parent:

    ALA3745775

    ---

Associated Targets(Human)

HPN Tchem Serine protease hepsin (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

St14 Suppressor of tumorigenicity 14 protein homolog (12 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 652.82Molecular Weight (Monoisotopic): 652.3479AlogP: -1.01#Rotatable Bonds: 22
Polar Surface Area: 277.37Molecular Species: BASEHBA: 10HBD: 9
#RO5 Violations: 2HBA (Lipinski): 16HBD (Lipinski): 12#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.65CX Basic pKa: 11.46CX LogP: -3.12CX LogD: -7.54
Aromatic Rings: 1Heavy Atoms: 45QED Weighted: 0.03Np Likeness Score: 0.02

References

1. Kwon H, Kim Y, Park K, Choi SA, Son SH, Byun Y..  (2016)  Structure-based design, synthesis, and biological evaluation of Leu-Arg dipeptide analogs as novel hepsin inhibitors.,  26  (2): [PMID:26711145] [10.1016/j.bmcl.2015.12.023]

Source